Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.

Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design. Future Oncol. 2022 May; 18(14):1669-1678.

View in: PubMed

subject areas

Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Chemoradiotherapy
Cisplatin
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Head and Neck Neoplasms
Humans
Randomized Controlled Trials as Topic

authors with profiles

Ezra Cohen